Bayer’s Eylea shows pandemic resilience, but major China price cut drags on business aliu Tue, 08/04/2020 – 10:10 More: Bayer's Eylea shows pandemic resilience, but major China price cut drags on business Source: fierce
read moreWith AstraZeneca deal, Wockhardt joins U.K.’s coronavirus vaccine manufacturing push fkansteiner Tue, 08/04/2020 – 09:53 More: With AstraZeneca deal, Wockhardt joins U.K.'s coronavirus vaccine manufacturing push Source: fierce
read moreDrug approved to treat major depressive disorder with acute suicidal ideation or behaviour More: Janssen’s depression nasal spray Spravato bags new FDA approval Source: News
read moreAgreement will utilise Oxford Biomedica’s LentiVector platform More: Oxford Biomedica and Beam Therapeutics sign CAR-T deal Source: News
read moreTherapy has been approved to treat advanced NTRK fusion-positive solid tumours More: Roche’s tumour-agnostic therapy Rozlytrek approved in EU Source: News
read moreNew deal with Wockhardt boosts capacity at the crucial ‘fill and finish’ stage More: UK increases COVID-19 vaccine manufacturing capacity Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals